C. Holick

First name

C.

Middle name

N.

Last name

Holick

Re, 3rd. L. , V, Haynes, K. ., Ming, E. E., Ives, W. ., Horne, L. N., Fortier, K. ., … Strom, B. L. (2012). Safety of saxagliptin: rationale for and design of a series of postmarketing observational studies. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.3318

View

Saine, M. E., Carbonari, D. M., Newcomb, C. W., Nezamzadeh, M. S., Haynes, K. ., Roy, J. A., … Re, V. 3rd L. (2015). Determinants of saxagliptin use among patients with type 2 diabetes mellitus treated with oral anti-diabetic drugs. BMC Pharmacol Toxicol. http://doi.org/10.1186/s40360-015-0007-z

View